Compounds > oxazolidin-2-one
Page last updated: 2024-08-25

oxazolidin-2-one and ta-8995

oxazolidin-2-one has been researched along with ta-8995 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barkas, F; Elisaf, M; Filippatos, TD; Klouras, E1
Avorn, J; Franklin, JM; Hey, SP; Kesselheim, AS1

Reviews

2 review(s) available for oxazolidin-2-one and ta-8995

ArticleYear
Cholesteryl ester transfer protein inhibitors: challenges and perspectives.
    Expert review of cardiovascular therapy, 2016, Volume: 14, Issue:8

    Topics: Amides; Anticholesteremic Agents; Benzodiazepines; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Esters; Humans; Lipids; Lipoprotein(a); Lipoproteins, HDL; Oxazolidinones; Quinolines; Sulfhydryl Compounds

2016
Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.
    Circulation. Cardiovascular quality and outcomes, 2017, Volume: 10, Issue:6

    Topics: Amides; Anticholesteremic Agents; Benzodiazepines; Biomarkers, Pharmacological; Cholesterol Ester Transfer Proteins; Drug Approval; Drug Discovery; Dyslipidemias; Endpoint Determination; Esters; Humans; Lipids; Oxazolidinones; Predictive Value of Tests; Quinolines; Reproducibility of Results; Sulfhydryl Compounds; Time Factors; Treatment Outcome

2017